[Development and trial of a heterogenous antistaphylococcal gamma-globulin].
Antitoxic and antibacterial equine gamma globulin for the treatment of staphylococcal infection has been developed and introduced into medical practice. The pronounced effectiveness of the preparation has been demonstrated in comparison with the ineffectiveness of traditional therapeutic measures. The development of mild forms of the serum disease in 33% of cases indicates that further investigations on the purification of gamma globulin preparations are necessary.
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006736:Horses / Q000276:immunology; D006801:Humans; D007114:Immunization / Q000379:methods; D007116:Immunization, Passive; D051379:Mice; D013203:Staphylococcal Infections / Q000517:prevention & control / Q000628:therapy; D013208:Staphylococcal Toxoid / Q000276:immunology; D013210:Staphylococcus / Q000276:immunology*; D005719:gamma-Globulins / Q000276:immunology / Q000302:isolation & purification*
D000907:Antibodies, Bacterial; D013208:Staphylococcal Toxoid; D005719:gamma-Globulins
Razrabotka i ispytaniie geterogennogo protivostafilokokkogo gamma-globulina.